ReviewRSC advances2019

Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Mehvash Zaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.